Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Q&A: EU Medtech Industry Joins Growing Opposition To HTA Regulation Proposal

Executive Summary

The European Commission's landmark proposal on health technology assessment regulation is meeting with a growing force of opposition. MedTech Europe’s Yves Verboven believes there are better solutions.

You may also be interested in...



Medtech Makes Headway In EU HTA Debate, But More Concessions Sought

The European Parliament adopted legislation that would establish an EU-wide system for joint clinical health technology assessments including amendments supported by the device industry. But companies are looking to make the plan less prescriptive when it moves to the EU Council.

Long Hold Up Anticipated In Council of EU As Member States Battle Over HTA Proposal

Highly divergent views among member states on the European Commission's proposal for a Health Technology Assessment Regulation are likely to lead to delays as ministers struggle to agree on a revised text.

Could EU's New HTA Proposal Promote EU-Wide Reimbursement Of Personalized Medicine?

Personalized medicine has yet to really take off in the EU. One of the main barriers are the fragmented rules around reimbursement. Could the European Commission's health technology assessment proposal help?

Related Content

Topics

Latest News
UsernamePublicRestriction

Register

MT122578

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel